HLA-E*0103 has been associated with higher susceptibility to cancer diseases such as acute leukemia [64] and ovarian cancer [65], as well as with an increased risk of mortality in patients with chronic lymphocytic leukemia [66]. Here, HLA-E is linked to acute leukemia.